Related Experiment Video
Updated: Jun 23, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
Cystatin C in acute heart failure without advanced renal impairment
Hiroyuki Naruse1, Junnichi Ishii, Tomoko Kawai
1Department of Internal Medicine, Fujita Health University School of Medicine, Toyoake, Japan.
Insights
Cystatin C measurement improves early risk stratification in acute heart failure patients with mild renal impairment, outperforming the Modification of Diet in Renal Disease (MDRD) equation for predicting cardiac mortality.
Area of Science:
- Cardiology
- Nephrology
- Biomarkers
Background:
- Assessing renal function in acute heart failure (AHF) is crucial for risk stratification.
- The prognostic value of cystatin C versus estimated glomerular filtration rate (eGFR) using the Modification of Diet in Renal Disease (MDRD) equation in AHF patients with normal to moderate renal impairment remains understudied.
- Improved detection of mild renal impairment may enhance risk stratification in these patients.
Purpose of the Study:
- To investigate the prognostic value of cystatin C compared to eGFR (MDRD) in predicting cardiac mortality in AHF patients with preserved renal function.
- To determine if cystatin C offers superior risk stratification compared to eGFR (MDRD) in this specific patient cohort.
Main Methods:
- A cohort of 328 consecutive patients hospitalized for worsening chronic heart failure with eGFR (MDRD) ≥30 mL/min/1.73 m² were enrolled.
- Cystatin C and creatinine levels were measured upon admission.
- Patients were followed for a median of 915 days to ascertain cardiac deaths.
Main Results:
- Cystatin C, but not eGFR (MDRD), was independently associated with cardiac mortality (P <.0001) in Cox regression analyses.
- Kaplan-Meier and adjusted relative risk analyses indicated cystatin C better separated low-risk from high-risk patients.
- Receiver-operating characteristic curve analyses demonstrated higher precision of cystatin C in predicting cardiac mortality.
Conclusions:
- Cystatin C measurement may enhance early risk stratification in acute heart failure patients with normal to moderately impaired renal function.
- Cystatin C appears to be a more precise predictor of cardiac mortality than eGFR (MDRD) in this population.
Background:
The prognostic value of cystatin C relative to glomerular filtration rate (GFR) estimated by the Modification of Diet in Renal Disease Study (MDRD) equation modified for Japan has not been investigated in acute heart failure patients with normal to moderately impaired renal function. More accurate detection of mild renal impairment might improve the risk stratification of heart failure patients, especially patients with normal to moderately impaired renal function.
Methods:
Cystatin C and creatinine levels were measured on admission in 328 consecutive patients hospitalized for worsening chronic heart failure with a GFR estimated by MDRD equation modified for Japan >or=30 mL/min/1.73 m(2).
Results:
During a median follow-up period of 915 days, there were 52 (16%) cardiac deaths. In stepwise Cox regression analyses including cystatin C and GFR estimated by MDRD equation modified for Japan (either as continuous variables or as variables categorized into quartiles), cystatin C (P <.0001), but not GFR estimated by MDRD equation modified for Japan, was independently associated with cardiac mortality. Adjusted relative risk according to the quartiles of these markers and Kaplan-Meier analyses revealed that the cystatin C was a better marker to separate low-risk from high-risk patients. Furthermore, receiver-operating characteristic curve analyses of these markers revealed that cystatin C showed a higher precision in predicting cardiac mortality.
Conclusion:
Measurements of cystatin C might improve early risk stratification compared with GFR estimated by MDRD equation modified for Japan in acute heart failure patients with normal to moderately impaired renal function.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury V: Interprofessional Care
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury I: Introduction
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Heart Failure IV: Classification and Diagnostic Evaluation